NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR
PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at leas...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CAMPETA ANTHONY MICHAEL MCLAUGHLING ROBERT WILLIAM SINGER ROBERT ALAN CHEKAL BRIAN PATRICK |
| description | PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at least one polymorphic form represented by formula 1 or a therapeutic or prophylactic use of such polymorphic form and a composition comprising the same. COPYRIGHT: (C)2009,JPO&INPIT |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2009019030A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2009019030A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2009019030A3</originalsourceid><addsrcrecordid>eNrjZNDwcw1XcA6KDA5x9PHx9HNVcPMP8lXwd1MIc3V30w1S8PTz8HTyDPEP4mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgYGlgaGlgbGBo7GRCkCAERvJF8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR</title><source>esp@cenet</source><creator>CAMPETA ANTHONY MICHAEL ; MCLAUGHLING ROBERT WILLIAM ; SINGER ROBERT ALAN ; CHEKAL BRIAN PATRICK</creator><creatorcontrib>CAMPETA ANTHONY MICHAEL ; MCLAUGHLING ROBERT WILLIAM ; SINGER ROBERT ALAN ; CHEKAL BRIAN PATRICK</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at least one polymorphic form represented by formula 1 or a therapeutic or prophylactic use of such polymorphic form and a composition comprising the same. COPYRIGHT: (C)2009,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090129&DB=EPODOC&CC=JP&NR=2009019030A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090129&DB=EPODOC&CC=JP&NR=2009019030A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAMPETA ANTHONY MICHAEL</creatorcontrib><creatorcontrib>MCLAUGHLING ROBERT WILLIAM</creatorcontrib><creatorcontrib>SINGER ROBERT ALAN</creatorcontrib><creatorcontrib>CHEKAL BRIAN PATRICK</creatorcontrib><title>NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR</title><description>PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at least one polymorphic form represented by formula 1 or a therapeutic or prophylactic use of such polymorphic form and a composition comprising the same. COPYRIGHT: (C)2009,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwcw1XcA6KDA5x9PHx9HNVcPMP8lXwd1MIc3V30w1S8PTz8HTyDPEP4mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgYGlgaGlgbGBo7GRCkCAERvJF8</recordid><startdate>20090129</startdate><enddate>20090129</enddate><creator>CAMPETA ANTHONY MICHAEL</creator><creator>MCLAUGHLING ROBERT WILLIAM</creator><creator>SINGER ROBERT ALAN</creator><creator>CHEKAL BRIAN PATRICK</creator><scope>EVB</scope></search><sort><creationdate>20090129</creationdate><title>NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR</title><author>CAMPETA ANTHONY MICHAEL ; MCLAUGHLING ROBERT WILLIAM ; SINGER ROBERT ALAN ; CHEKAL BRIAN PATRICK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2009019030A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CAMPETA ANTHONY MICHAEL</creatorcontrib><creatorcontrib>MCLAUGHLING ROBERT WILLIAM</creatorcontrib><creatorcontrib>SINGER ROBERT ALAN</creatorcontrib><creatorcontrib>CHEKAL BRIAN PATRICK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAMPETA ANTHONY MICHAEL</au><au>MCLAUGHLING ROBERT WILLIAM</au><au>SINGER ROBERT ALAN</au><au>CHEKAL BRIAN PATRICK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR</title><date>2009-01-29</date><risdate>2009</risdate><abstract>PROBLEM TO BE SOLVED: To provide a polymorphic form of 6-[2-(methyIcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole which is useful when treating abnormal cell proliferation of mammal cancer, etc. SOLUTION: The present invention provides a pharmaceutical composition containing at least one polymorphic form represented by formula 1 or a therapeutic or prophylactic use of such polymorphic form and a composition comprising the same. COPYRIGHT: (C)2009,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2009019030A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NEW CRYSTALLINE FORM OF VEGF-R INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A05%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAMPETA%20ANTHONY%20MICHAEL&rft.date=2009-01-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2009019030A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |